Full Press Release Details
HAMPTON, N.J., Feb. 13, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today upcoming investor events for February and March.
Upcoming Investor Conferences
Anthony Marucci, Co-founder, President and Chief Executive Officer, and Thomas Davis, M.D., Executive Vice President and Chief Medical Officer, will participate in presentations at the following conferences:
Leerink Partners 6th Annual Global Healthcare Conference on Wednesday, February 15, 2017 at 9:30 a.m. EST in New York – fireside chat
Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017 at 9:20 a.m. EST in Boston – corporate presentation
Live webcasts of the presentations will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentations will be available for seven days following each event.
2016 Year-End Results and Conference Call/Webcast
Celldex will release fourth quarter and year-end 2016 financial results on Tuesday, March 14, 2017 after the U.S. financial markets close.
Celldex will host a conference call/webcast at 4:30 p.m. EDT on the same day to provide an in-depth update on its pipeline and upcoming milestones for 2017.
Event details, including conference call phone numbers, can be accessed on the "Events & Presentations" page under the "Investors & Media" section of the Celldex website.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.
Contact Data
Vice President of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
Associate Director of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
Contact
With a Reader Account, it's easy to send email directly to the contact for this release. Sign up today for your free Reader Account!
Already have an account? Log in here.